Epithalon Therapy

Epithalon's primary mechanism involves the activation of telomerase, the enzyme responsible for adding protective telomeric sequences to the ends of chromosomes. Telomere shortening is a hallmark of cellular aging, and telomerase activation may slow or partially reverse this process. Epithalon also stimulates the pineal gland to produce melatonin, restoring the age-related decline in melatonin synthesis that contributes to circadian disruption and reduced antioxidant defense. Additionally, the peptide has been shown in preclinical research to influence gene expression patterns associated with aging, potentially normalizing age-related changes in multiple organ systems.

Epithalon is primarily sought by individuals deeply invested in longevity and anti-aging science who understand the significance of telomere biology. Patients in their 40s and beyond who are proactively seeking to address the underlying mechanisms of aging rather than individual symptoms are the most common candidates. The peptide is also popular within the biohacking community and among those following comprehensive age-management protocols.

Epithalon is typically administered via subcutaneous injection. The most common protocol involves daily injections for 10 to 20 consecutive days, repeated two to three times per year. Some practitioners use longer intervals between courses. Dosing and frequency are determined by the supervising clinician based on the patient's age, health status, and longevity goals.